Literature DB >> 7528772

ZAP-70 binding specificity to T cell receptor tyrosine-based activation motifs: the tandem SH2 domains of ZAP-70 bind distinct tyrosine-based activation motifs with varying affinity.

N Isakov1, R L Wange, W H Burgess, J D Watts, R Aebersold, L E Samelson.   

Abstract

Engagement of the T cell antigen receptor (TCR) results in activation of several tyrosine kinases leading to tyrosine phosphorylation of protein substrates and activation of multiple biochemical pathways. TCR-mediated activation of the src-family kinases, Lck and Fyn, results in tyrosine phosphorylation of the TCR zeta and CD3 chains. The site of phosphorylation in these chains is the tyrosine-based activation motif (TAM), a 15-16 amino acid module containing two tyrosine residues. Tyrosine-phosphorylated TAMs serve as targets for binding of the zeta-associated protein (ZAP-70) tyrosine kinase via its tandem SH2 domains. This binding correlates with activation of ZAP-70, a critical event in T cell activation. To further define the structural requirements for ZAP-70 interaction with the TCR, we developed a binding assay using immobilized glutathione S-transferase fusion proteins containing the NH2- and/or COOH-terminal SH2 domains of ZAP-70, and soluble synthetic peptides with the sequence of the cytoplasmic region of the TCR zeta chain (TCR zeta cyt) or individual TCR zeta and CD3 epsilon TAM motifs. Direct binding studies demonstrated that the tandem ZAP-70 SH2 domains bind phosphorylated, but not nonphosphorylated, TCR zeta cyt. The NH2-terminal ZAP-70 SH2 domain also binds to TCR zeta cyt but with 100-fold lower affinity. No binding was observed with the COOH-terminal ZAP-70 SH2 domain. Similar studies demonstrated that the ZAP-70 tandem SH2 domain can bind a TCR zeta 3 TAM peptide in which both tyrosine residues are phosphorylated: Little or no binding was observed with peptides phosphorylated at only one tyrosine residue, or a nonphosphorylated peptide. Binding of the tandem SH2 domains to the other two TCR zeta TAM peptides and to a CD3 epsilon TAM peptide was also observed. All four doubly tyrosine phosphorylated TAM peptides cross-compete with each other for binding to the tandem SH2 domains of ZAP-70. The affinity of these peptides for the tandem SH2 construct demonstrated a hierarchy of TAM zeta 1 > or = TAM zeta 2 > TAM epsilon > or = TAM zeta 3. The results provide further evidence that the ZAP-70 interaction with the TCR requires prior phosphorylation of both tyrosine residues within a TAM motif. Binding of ZAP-70 to phospho-TAMs is notable for the high level of cooperativity between the two SH2 domains, which individually demonstrate low affinity interaction with the ligand. The cooperativity ensures higher affinity for the doubly phosphorylated ligand. Affinity differences of as much as 30-fold indicates a significant specificity of interaction of ZAP-70 SH2 domains for different phospho-TAMs.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7528772      PMCID: PMC2191847          DOI: 10.1084/jem.181.1.375

Source DB:  PubMed          Journal:  J Exp Med        ISSN: 0022-1007            Impact factor:   14.307


  24 in total

Review 1.  Tyrosine kinases and tyrosine-based activation motifs. Current research on activation via the T cell antigen receptor.

Authors:  L E Samelson; R D Klausner
Journal:  J Biol Chem       Date:  1992-12-15       Impact factor: 5.157

2.  Activation of T cells by a tyrosine kinase activation domain in the cytoplasmic tail of CD3 epsilon.

Authors:  F Letourneur; R D Klausner
Journal:  Science       Date:  1992-01-03       Impact factor: 47.728

3.  The T cell receptor/CD3 complex is composed of at least two autonomous transduction modules.

Authors:  A M Wegener; F Letourneur; A Hoeveler; T Brocker; F Luton; B Malissen
Journal:  Cell       Date:  1992-01-10       Impact factor: 41.582

4.  Sequence requirements for induction of cytolysis by the T cell antigen/Fc receptor zeta chain.

Authors:  C Romeo; M Amiot; B Seed
Journal:  Cell       Date:  1992-03-06       Impact factor: 41.582

5.  Antigen receptor tail clue.

Authors:  M Reth
Journal:  Nature       Date:  1989-03-30       Impact factor: 49.962

6.  Multiple components of the T cell antigen receptor complex become tyrosine-phosphorylated upon activation.

Authors:  D Qian; I Griswold-Prenner; M R Rosner; F W Fitch
Journal:  J Biol Chem       Date:  1993-02-25       Impact factor: 5.157

7.  The zeta chain is associated with a tyrosine kinase and upon T-cell antigen receptor stimulation associates with ZAP-70, a 70-kDa tyrosine phosphoprotein.

Authors:  A C Chan; B A Irving; J D Fraser; A Weiss
Journal:  Proc Natl Acad Sci U S A       Date:  1991-10-15       Impact factor: 11.205

8.  The cytoplasmic domain of the T cell receptor zeta chain is sufficient to couple to receptor-associated signal transduction pathways.

Authors:  B A Irving; A Weiss
Journal:  Cell       Date:  1991-03-08       Impact factor: 41.582

9.  A tyrosine-phosphorylated 70-kDa protein binds a photoaffinity analogue of ATP and associates with both the zeta chain and CD3 components of the activated T cell antigen receptor.

Authors:  R L Wange; A N Kong; L E Samelson
Journal:  J Biol Chem       Date:  1992-06-15       Impact factor: 5.157

10.  Purification and initial characterization of the lymphocyte-specific protein-tyrosyl kinase p56lck from a baculovirus expression system.

Authors:  J D Watts; G M Wilson; E Ettenhadieh; I Clark-Lewis; C A Kubanek; C R Astell; J D Marth; R Aebersold
Journal:  J Biol Chem       Date:  1992-01-15       Impact factor: 5.157

View more
  45 in total

Review 1.  T cell signal transduction and the role of CD7 in costimulation.

Authors:  R Stillwell; B E Bierer
Journal:  Immunol Res       Date:  2001       Impact factor: 2.829

Review 2.  Positive and negative regulation of T-cell activation through kinases and phosphatases.

Authors:  Tomas Mustelin; Kjetil Taskén
Journal:  Biochem J       Date:  2003-04-01       Impact factor: 3.857

3.  CD3 delta deficiency arrests development of the alpha beta but not the gamma delta T cell lineage.

Authors:  V P Dave; Z Cao; C Browne; B Alarcon; G Fernandez-Miguel; J Lafaille; A de la Hera; S Tonegawa; D J Kappes
Journal:  EMBO J       Date:  1997-03-17       Impact factor: 11.598

4.  Maintenance of murine platelet homeostasis by the kinase Csk and phosphatase CD148.

Authors:  Jun Mori; Zoltan Nagy; Giada Di Nunzio; Christopher W Smith; Mitchell J Geer; Rashid Al Ghaithi; Johanna P van Geffen; Silke Heising; Luke Boothman; Bibian M E Tullemans; Joao N Correia; Louise Tee; Marijke J E Kuijpers; Paul Harrison; Johan W M Heemskerk; Gavin E Jarvis; Alexander Tarakhovsky; Arthur Weiss; Alexandra Mazharian; Yotis A Senis
Journal:  Blood       Date:  2018-01-04       Impact factor: 22.113

5.  Molecular mechanism of selective recruitment of Syk kinases by the membrane antigen-receptor complex.

Authors:  Peter J Bond; José D Faraldo-Gómez
Journal:  J Biol Chem       Date:  2011-05-21       Impact factor: 5.157

6.  Characterization of the roles of SH2 domain-containing proteins in T-lymphocyte activation by using dominant negative SH2 domains.

Authors:  J P Northrop; M J Pustelnik; A T Lu; J R Grove
Journal:  Mol Cell Biol       Date:  1996-05       Impact factor: 4.272

Review 7.  Induction and stability of the anergic phenotype in T cells.

Authors:  Rut Valdor; Fernando Macian
Journal:  Semin Immunol       Date:  2013-11-05       Impact factor: 11.130

Review 8.  Organization of proximal signal initiation at the TCR:CD3 complex.

Authors:  Clifford S Guy; Dario A A Vignali
Journal:  Immunol Rev       Date:  2009-11       Impact factor: 12.988

9.  Qualitative and quantitative contributions of the T cell receptor zeta chain to mature T cell apoptosis.

Authors:  B Combadière; M Freedman; L Chen; E W Shores; P Love; M J Lenardo
Journal:  J Exp Med       Date:  1996-05-01       Impact factor: 14.307

10.  Selective phosphorylation of the Dlg1AB variant is critical for TCR-induced p38 activation and induction of proinflammatory cytokines in CD8+ T cells.

Authors:  Jillian Crocetti; Oscar Silva; Lisa A Humphries; Michelle D Tibbs; M Carrie Miceli
Journal:  J Immunol       Date:  2014-08-06       Impact factor: 5.422

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.